DE69803642D1 - Hydroxy und Polyhydroxy Derivate von Coumarin, deren Herstellung und deren antivirale Wirkung - Google Patents

Hydroxy und Polyhydroxy Derivate von Coumarin, deren Herstellung und deren antivirale Wirkung

Info

Publication number
DE69803642D1
DE69803642D1 DE69803642T DE69803642T DE69803642D1 DE 69803642 D1 DE69803642 D1 DE 69803642D1 DE 69803642 T DE69803642 T DE 69803642T DE 69803642 T DE69803642 T DE 69803642T DE 69803642 D1 DE69803642 D1 DE 69803642D1
Authority
DE
Germany
Prior art keywords
coumarin
hydroxy
polyhydroxy derivatives
production
antiviral activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69803642T
Other languages
English (en)
Other versions
DE69803642T2 (de
Inventor
Mladen Prof Dr Trkovnik
Zrinka Ivezic
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Farmaceutika dd
Original Assignee
Pliva Farmaceutska Kemijska Prehrambena I Kozmeticka Industrija dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska Kemijska Prehrambena I Kozmeticka Industrija dd filed Critical Pliva Farmaceutska Kemijska Prehrambena I Kozmeticka Industrija dd
Application granted granted Critical
Publication of DE69803642D1 publication Critical patent/DE69803642D1/de
Publication of DE69803642T2 publication Critical patent/DE69803642T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/44Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
    • C07D311/46Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/44Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/44Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3
    • C07D311/46Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring
    • C07D311/48Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 with one hydrogen atom in position 3 unsubstituted in the carbocyclic ring with two such benzopyran radicals linked together by a carbon chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/42Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
    • C07D311/56Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69803642T 1997-10-02 1998-09-30 Hydroxy und Polyhydroxy Derivate von Coumarin, deren Herstellung und deren antivirale Wirkung Expired - Fee Related DE69803642T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HR970529A HRP970529B1 (en) 1997-10-02 1997-10-02 Novel hydroxy and polyhydroxy derivatives of cumarin, preparation thereof and antiviral action thereof

Publications (2)

Publication Number Publication Date
DE69803642D1 true DE69803642D1 (de) 2002-03-14
DE69803642T2 DE69803642T2 (de) 2002-10-02

Family

ID=10946634

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69803642T Expired - Fee Related DE69803642T2 (de) 1997-10-02 1998-09-30 Hydroxy und Polyhydroxy Derivate von Coumarin, deren Herstellung und deren antivirale Wirkung

Country Status (22)

Country Link
US (2) US6100409A (de)
EP (1) EP0906909B1 (de)
JP (3) JP3139996B2 (de)
CN (1) CN1101814C (de)
AT (1) ATE212625T1 (de)
AU (1) AU747394B2 (de)
BG (1) BG63543B1 (de)
CA (1) CA2246052A1 (de)
CZ (1) CZ314398A3 (de)
DE (1) DE69803642T2 (de)
DK (1) DK0906909T3 (de)
ES (1) ES2172072T3 (de)
HR (1) HRP970529B1 (de)
HU (1) HUP9802178A3 (de)
NO (1) NO984590L (de)
NZ (1) NZ332147A (de)
PL (1) PL328935A1 (de)
PT (1) PT906909E (de)
RU (1) RU2207338C2 (de)
SI (1) SI0906909T1 (de)
SK (1) SK283173B6 (de)
UA (1) UA63903C2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP970529B1 (en) * 1997-10-02 2003-06-30 Pliva Pharm & Chem Works Novel hydroxy and polyhydroxy derivatives of cumarin, preparation thereof and antiviral action thereof
CA2462414A1 (en) * 2001-10-01 2003-04-10 Pliva, Farmaceutska Industrija, Dionicko Drustvo Products of condensations of hydroxycoumarin derivatives with aromatic and aliphatic dialdehydes, their preparation and antiviral action thereof
HRP20030604A2 (en) * 2003-07-25 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromenes, preparation thereof andtheir antiinflammatory action
HRP20030603A2 (en) 2003-07-25 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromene compounds of antiinflammatory action
DE102009029050A1 (de) * 2009-08-31 2011-03-03 Evonik Oxeno Gmbh Organophosphorverbindungen basierend auf Tetraphenol(TP)-substituierten Strukturen
JP6863067B2 (ja) * 2017-05-17 2021-04-21 Dic株式会社 δ−バレロラクトン骨格含有樹脂
CN111297851B (zh) * 2020-04-02 2021-03-23 中国农业科学院蜜蜂研究所 香豆素在蜜蜂抗病毒感染中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672607A (en) * 1993-01-29 1997-09-30 The United States Of America As Represented By The Department Of Health And Human Services Antiviral naphthoquinone compounds, compositions and uses thereof
HRP970529B1 (en) * 1997-10-02 2003-06-30 Pliva Pharm & Chem Works Novel hydroxy and polyhydroxy derivatives of cumarin, preparation thereof and antiviral action thereof

Also Published As

Publication number Publication date
CZ314398A3 (cs) 1999-05-12
NO984590L (no) 1999-04-06
AU747394B2 (en) 2002-05-16
DE69803642T2 (de) 2002-10-02
ATE212625T1 (de) 2002-02-15
UA63903C2 (uk) 2004-02-16
NO984590D0 (no) 1998-10-01
ES2172072T3 (es) 2002-09-16
HRP970529A2 (en) 1999-06-30
HUP9802178A3 (en) 2002-05-28
JPH11158169A (ja) 1999-06-15
EP0906909B1 (de) 2002-01-30
US6100409A (en) 2000-08-08
AU8788698A (en) 1999-04-22
JP2001089467A (ja) 2001-04-03
BG102813A (en) 1999-07-30
SK136798A3 (en) 1999-05-07
EP0906909A1 (de) 1999-04-07
NZ332147A (en) 1999-05-28
US6291518B1 (en) 2001-09-18
BG63543B1 (bg) 2002-04-30
CN1220263A (zh) 1999-06-23
SK283173B6 (sk) 2003-03-04
SI0906909T1 (en) 2002-06-30
CA2246052A1 (en) 1999-04-02
PT906909E (pt) 2002-07-31
RU2207338C2 (ru) 2003-06-27
PL328935A1 (en) 1999-04-12
JP3139996B2 (ja) 2001-03-05
HU9802178D0 (en) 1998-11-30
DK0906909T3 (da) 2002-04-29
HUP9802178A2 (hu) 2000-05-28
JP2001089466A (ja) 2001-04-03
HRP970529B1 (en) 2003-06-30
CN1101814C (zh) 2003-02-19

Similar Documents

Publication Publication Date Title
MX9200817A (es) Derivados de piranil cianoguanidina y proceso para su preparacion.
DE69114614D1 (de) Polyethylenglykolderivate, modifizierte Peptide derselben, ihre Herstellung sowie Verwendung der modifizierten Peptide.
HUT49600A (en) Process for producing substituted flavonoid deriatives and salts, thereof, as well as pharmaceutical compositions comprising such compounds
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ES2063186T3 (es) Derivados ftalinida, composicion farmaceutica y uso.
FI930974A0 (fi) Substituerade aminofosfonatderivat, foerfarande foer framstaellning av desamma och farmaceutiska kompositioner innehaollande desamma
DE69803642T2 (de) Hydroxy und Polyhydroxy Derivate von Coumarin, deren Herstellung und deren antivirale Wirkung
DE3485419D1 (de) Glyzerinderivate.
DE69328728T2 (de) Herstellung von derivaten von a-acetyl neuraminicsäuren
DE3781879D1 (de) Anthracyclinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
BA97239A (bs) Novi derivati kumarina postupci za njihovu pripravu i uporaba
ES2182451T3 (es) Procedimiento para la obtencion de derivados de cromano substituidos.
NO842345L (no) Heksahydropyrrolo(2,1-a)isoquinolin-derivater.
ES2033256T3 (es) Procedimiento para preparar derivados fluorados de la vitamina d3.
ES2089159T3 (es) Nuevos derivados de acido ascorbico.
HK1049152A1 (en) 1,4-dihydropyridine-5-carboxylic acid ester derivatives and method for the preparation thereof
ITMI920082A1 (it) Derivati solforati di acidi biliari
ATE239699T1 (de) Hydroxyphenylsulfanylbenzoesäure- und - arylessigsäure-derivate
ATE104270T1 (de) Glutarsaeurederivate und ihre herstellung.
ES2048090A1 (es) Procedimiento para la obtencion de nuevos antitromboticos derivados de la cumarina.
ES2051722T3 (es) Procedimiento para estabilizar derivados de procaterol.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee